weight loss

Vivus Adds 12% in Early Trading on Qnexa Study Results

blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Quiksilver: The Losing Streak Continues ...

Shares of Quiksilver (NYSE:ZQK) traded at a new 52-week low today of $2.86. This new l ...

National Fuel Gas's Shares Changing Hand...

National Fuel Gas shares are trading on heavy volume today, having risen 0.2% to $69.02 ...

Shares of EXCO Resources Fall to a New 5...

Shares of EXCO Resources (NYSE:XCO) traded at a new 52-week low today of $4.45. This n ...

Shares of National Grid Are Moving Lower...

National Grid's stock is down 1.9% to $70.40 on heavy trading volume. Approximately 55 ...

Watch for Continued Gains in Shares of U...

U.S. Steel (NYSE:X) traded today at a new 52-week high of $34.73. So far today approxi ...

Volume Spike Detected in Shares of Rovi ...

Shares of Rovi are trading today in above average volume, with the share price falling ...

Web.com Group Inc: New 52-Week Low Set T...

Web.com Group Inc (NASDAQ:WWWW) traded today at a new 52-week low of $19.36. So far to ...

Shares of Torchmark Have Fallen Below Pr...

Torchmark (NYSE:TMK) traded today at a new 52-week low of $52.05. This new low was rea ...

Most Popular Video News